A Trial Investigating Lu AF82422 in Healthy Chinese and Caucasian Adults

Inclusion Criteria: * For Chinese participants only: The participant is Chinese, defined as having four Chinese grandparents. * For Caucasian participants only: The participant is Caucasian, defined as having four Caucasian grandparents. * The participant has a Body Mass Index (BMI) ≥19 and ≤26 kilograms per square meter (kg/m2) at the Screening Visit and at the Baseline Visit. * The participant is, in the opinion of the investigator, generally healthy based on medical history, a physical examination, a neurological examination, vital signs, an electrocardiogram (ECG), and the results of the clinical chemistry, haematology, urinalysis, serology, and other laboratory tests. Exclusion Criteria: * The participant has previously been enrolled in this trial. * The participant has previously been dosed with Lu AF82422. * The participant has participated in a clinical trial \<30 days prior to the Screening Visit. * The participant has taken any investigational medicinal product \<3 months or \<5 half-lives of that product, whichever is longer, prior to administration of the IMP. * The participant is pregnant, breastfeeding, intends to become pregnant, or is of childbearing potential and not willing to use adequate contraceptive methods. Other protocol-defined criteria apply.